Bolt Biotherapeutics Appoints Sheila Gujrathi as Chief Strategy Officer
PUBLIC · BOLTOct 25, 2026
New to company · from Prana Therapies“co-founder and former CEO of Prana Therapies, has been appointed Chief Strategy Officer of Bolt Biotherapeutics following its acquisition of Prana”
Position
Chief Strategy Officer
Company
Bolt Biotherapeutics
Sheila Gujrathi, M.D.
Redwood CityOtherBiotechnology
Description
Sheila Gujrathi, M.D., co-founder and former CEO of Prana Therapies, has been appointed Chief Strategy Officer of Bolt Biotherapeutics following its acquisition of Prana. This strategic hire aims to strengthen Bolt's focus on advancing its lead program and maximizing the potential of its innovative pipeline.
Who to call at Bolt Biotherapeutics, and when
A new leader at Bolt Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Bolt Biotherapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Bolt Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bolt Biotherapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Bolt Biotherapeutics
Location
900 CHESAPEAKE DRIVE
Redwood City, California, United States
About
Bolt Biotherapeutics is a Nasdaq-listed (BOLT) biotechnology company. It announced the acquisition of Prana Therapies alongside a $120 million concurrent private placement. The company will advance Prana's PRA-216 pipeline in inflammatory indications.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bolt Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Redwood CityOtherBiotechnology